Goldman Sachs
TIL icon

Goldman Sachs’s Instil Bio TIL Stock Holding History

Goldman Sachs’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-163,261
Closed -$3.4M – 6653
2025
Q2 		$3.4M Buy
163,261
+30,830
+23% +$645K ﹤0.01% 3777
2025
Q1 		$2.3M Buy
132,431
+5,504
+4% +$114K ﹤0.01% 4035
2024
Q4 		$2.42M Buy
+126,927
New +$3.87M ﹤0.01% 4118
2023
Q4 		– Sell
-1,586
Closed -$13.6K – 5848
2023
Q3 		$13.6K Sell
1,586
-146
-8% -$1.47K ﹤0.01% 5385
2023
Q2 		$19.1K Sell
1,732
-20,106
-92% -$246K ﹤0.01% 5554
2023
Q1 		$289K Sell
21,838
-3,925
-15% -$58K ﹤0.01% 5128
2022
Q4 		$325K Buy
25,763
+12,388
+93% +$612K ﹤0.01% 5104
2022
Q3 		$1.29M Buy
13,375
+877
+7% +$100K ﹤0.01% 4338
2022
Q2 		$1.16M Buy
12,498
+8,176
+189% +$1.16M ﹤0.01% 4503
2022
Q1 		$929K Buy
4,322
+233
+6% +$54.5K ﹤0.01% 4879
2021
Q4 		$1.4M Buy
4,089
+3,556
+667% +$1.37M ﹤0.01% 4561
2021
Q3 		$191K Buy
+533
New +$199K ﹤0.01% 5739
2021
Q2 		– Sell
-5,894
Closed -$2.96M – 6516
2021
Q1 		$2.96M Buy
+5,894
New +$3.02M ﹤0.01% 3604

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs's TIL Position: Q3 2025 in Review

Goldman Sachs sold out of Instil Bio (TIL) in Q3 2025, closing a stake of 163,261 shares — an estimated $3.4M sold.

Goldman Sachs first reported a position in TIL in Q1 2021 and held it in 13 quarters. The position peaked at $3.4M in Q2 2025. 34 funds tracked by Wall St. Rank hold TIL as of Q3 2025.

  • Goldman Sachs reported no remaining Instil Bio position as of Q3 2025 after selling out during the quarter.
  • Goldman Sachs sold 163,261 Instil Bio shares in Q3 2025, an estimated $3.4M.
  • Goldman Sachs first reported a position in Instil Bio in Q1 2021 and held it in 13 quarters.
  • Goldman Sachs's Instil Bio position peaked at $3.4M in Q2 2025.
  • 34 funds tracked by Wall St. Rank held Instil Bio as of Q3 2025.

Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.